Inward transport of 3H-MPP+ in freshly isolated rat hepatocytes: Evidence for interaction with catecholamines

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 3, 1996, Pages 305-311

  Martel, Fátima ^a   Martins, M João ^a   Azevedo, Isabel ^a  

^a Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

Catecholamines; Inward transport; MPP+; Rat hepatocytes

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,1' DIETHYL 2,2' CYANINE; 3',4' DIHYDROXY 2 METHYLPROPIOPHENONE; 3,5 DINITROPYROCATECHOL; ADRENALIN; CYANINE 863; DOPAMINE; ISOPRENALINE; NORADRENALIN; PARGYLINE; RO 01 2812; UNCLASSIFIED DRUG; 1 (4 METHOXYPHENYL)PYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 1-(4-METHOXYPHENYL)PYRIDINIUM; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; AMINE OXIDASE (FLAVIN CONTAINING); CARRIER PROTEIN; CATECHOLAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; PSEUDOISOCYANIN; PYRIDINIUM DERIVATIVE; QUINOLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG COMPETITION; DRUG TRANSPORT; DRUG UPTAKE; IN VITRO STUDY; LIVER CELL; MALE; NONHUMAN; RAT; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; LIVER; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CATECHOLAMINES; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIVER; MALE; MONOAMINE OXIDASE; NEUROTRANSMITTER AGENTS; PYRIDINIUM COMPOUNDS; QUINOLINES; RATS; RATS, WISTAR;

EID: 0029658637     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf00171061     Document Type: Article

References (40)

1. 3H-(±)-noradrenaline by isolated rat liver cells. Naunyn-Schmiedeberg's Arch Pharmacol 342:40-44
2. Bönisch H, Uhlig W, Trendelenburg U (1974) Analysis of the compartments involved in the extraneuronal storage and metabolism of isoprenaline in the perfused heart. Naunyn-Schmiedeberg's Arch Pharmacol 283:223- 244
3. i) and the concentration which causes 50% inhibition of enzymatic reaction. Biochem Pharmacol 22:403-411
4. Daniels AJ, Reinhard FJ Jr (1988) Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter. J Biol Chem 263: 5034-5036
5. Di Monte D, Ekstrom G, Shinka T, Smith MT, Trevor AJ, Castagnoli N Jr (1987) Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytes. Chem Biol Interact 62:105-116
6. Gerlach M, Riederer P, Przuntek H, Youdim MBH (1991) MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur J Pharmacol-Mol Pharmacol Sect 208:273-286
7. Gilles RE, Miller JW (1967) Studies on the potentiation of the ionotropic actions of certain catecholamines by U-0521 (3′,4′-dihydroxymethyl propiophenone). J Pharmacol Exp Ther 157: 55-61
8. Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H (1994) Drug excretion mediated by a new prototype of poly-specific transporter. Nature 372:549-552
9. + by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP. Eur J Pharmacol 106:455-456
10. Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism-inducing neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridinium by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82:2173-2177
11. 3H-epinephrine in the rat. J Biol Chem 237: 2291-2295
12. Kass GE, Wrighl KM, Nicotera P, Orrenius S (1988) The mechanism of 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium. Arch Biochem Biophys 260: 789-797
13. Klaassen CD, Watkins JBI (1984) Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol Rev 36:1-67
14. Kopin IJ (1992) Selective neurotoxicity. In: Herken H, Hucho F (eds) Handbook of Experimental Pharmacology, Vol. 102. Springer, Berlin Heidelberg New York, pp 333-356
15. + exchanger of renal brush-border membrane vesicles. Am J Physiol 258:F597-F605
16. Lightman SL, Hems DA (1973) Metabolism of adrenaline in the isolated perfused liver of the rat. Biochem Pharmacol 22:297-308
17. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
18. 3H] -( - )-noradrenaline in the perfused rat liver. J Auton Pharmacol 15:309-319
19. 3H-noradrenaline by isolated hepatocytes and liver slices of the rat. Naunyn-Schmiedeberg's Arch Pharmacol 348:350-357
20. 2. Naunyn-Schmiedeberg's Arch Pharmacol 350:130-135
21. +) by rat hepatocytes. Br J Pharmacol 114 [Suppl]:262P
22. Martel F, Vetter T, Russ H, Gründemann D, Azevedo I, Koepsell H (1996) Transport of small organic cations in the rat liver: the role of the organic cation transporter OCT 1. Naunyn-Schmiedeberg's Arch Pharmacol (in press)
23. Meijer DKF, Mol WEM, Müller M, Kurz G (1990) Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations. J Pharmacokinet Biopharm 18:35-70
24. Melamed E, Rosenthal J, Cohen O, Globus M, Uzzan A (1985) Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP. Fur J Pharmacol 116:179-181
25. Motulsky HJ, Ransnas LA (1987) Fitting curves to data using nonlinear regression: a practical and nonmathematical review. FASEB J 1:365-374
26. Neame KD, Richards TG (1972) Elementary kinetics of membrane carrier transport. Blackwell Scientific Publications, Oxford
27. Neef NH, Yang HYT (1974) Another look at the monoamine oxidases and the MAO inhibitor drugs. Life Sci 14:2061-2074
28. Pileblad E, Carlsson A (1985) Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) in mouse brain. Neuropharmacology 24:689-692
29. Rennick BR (1981) Renal tubule transport of organic cations. Am J Physiol 240:F83-F89
30. Rennick BR, Kandel L, Peters L (1956) Inhibition of the renal tubular excretion of tetraethylammonium and N′-methylnicotinamide by basic cyanine dyes. J Pharmacol Exp Ther 118:204-219
31. +). Naunyn-Schmiedeberg's Arch Pharmacol 346:158-165
32. Russ H, Sonna J, Keppler K, Baunach S, Schömig E (1993) Cyanine-relaled compounds: a novel class of potent inhibitors of extraneuronal noradrenaline transport. Naunyn-Schmiedeberg's Arch Pharmacol 348:458-465
33. Schömig E, Babin-Ebell J, Russ H (1993) 1,1′-diethyl-2,2′-cyanine (decynium22) potently inhibits the renal transport of organic cations. Naunyn-Schmiedeberg's Arch Pharmacol 347:379-383
34. Segel IH (1975) Enzyme kinetics: behavior and analysis of rapid equilibrium and steady-state enzyme systems. John Wiley, New York
35. Sokol PP, Holohan PD, Ross CR (1987) The neurotoxins 1-methyl-4-phenylpyridinium and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine are substrates for the organic cation transporter in renal brush border membrane vesicles. J Pharmacol Exp Ther 242:152-157
36. 2) exists in the central nervous system (CNS). Naunyn-Schmiedeberg's Arch Pharmacol 347: R118
37. 3H-(±)-noradrenaline in the isolated perfused rat liver. Naunyn-Schmideberg's Arch Pharmacol 337:392-396
38. Sweet LR, Martin WB, Taylor JD, Everett GM, Wykcs AA, Gladish YC (1963) Structure-activity relations in the pargyline series. Ann NY Acad Sci 107:891-898
39. Zimon RP, Tyce GM, Flock EV, Sheps SG, Owen CA Jr (1967) Effect of monoamine oxidase inhibition on biliary excretion of metabolites of norepinephrine by isolated rat liver. J Pharmacol Exp Ther 157:89-95
40. Zürcher G, Keller HH, Bruderer H, Borgulya J, Da Prada M (1988) Caratteristiche neurochimiche di una nuova classe di inhibitori della COMT attivi per via orale: livelli plasmatici de DOPA e 3-OMD nel ratto trattato con DOPA e benzerazide. In: Agnoli A, Battistin L (eds) Morbo di Parkinson e demenze: metodologie diagnostiche. Guanella SRL, Rome, pp 15-29